Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2

about

Dengue vaccines: recent developments, ongoing challenges and current candidates.The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.

P2860

Q34367194-390593F8-A534-44BE-B378-027A85EB14FB Q34614953-7FB2C6B4-CEE9-4DE0-8055-142CBFCAC225

P2860

Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2

Item

http://www.wikidata.org/entity/Q35624552

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@ast

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@en

type

Item

label

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@ast

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@en

prefLabel

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@ast

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@en

P1476

Distinct Humoral and Cellular ...... Protein of Dengue Virus Type 2

@en

P2093

Junu A George

http://www.w3.org/2001/XMLSchema#string

Seong Kug Eo

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue: defining protective versus pathologic immunity

Dengue fever: new paradigms for a changing epidemiology

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Understanding dengue pathogenesis: implications for vaccine design

Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2

Dengue

Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.

Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus.

P304

268-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4110/IN.2011.11.5.268

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51920825

http://www.w3.org/2001/XMLSchema#string

P698

22194710

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

Dengue virus

P932

3243001

http://www.w3.org/2001/XMLSchema#string

Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2

about

P2860

P2860

Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932